MedPath

TABLOID

TABLOID brand Thioguanine 40-mg Scored Tablets

Approved
Approval ID

344df8bc-b16d-4b75-b4c8-40de7d465849

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 29, 2022

Manufacturers
FDA

Woodward Pharma Services LLC

DUNS: 080406260

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

thioguanine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code69784-630
Application NumberNDA012429
Product Classification
M
Marketing Category
C73594
G
Generic Name
thioguanine
Product Specifications
Route of AdministrationORAL
Effective DateApril 15, 2022
FDA Product Classification

INGREDIENTS (6)

MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, POTATOInactive
Code: 8I089SAH3T
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
ACACIAInactive
Code: 5C5403N26O
Classification: IACT
THIOGUANINEActive
Quantity: 40 mg in 1 1
Code: FTK8U1GZNX
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TABLOID - FDA Drug Approval Details